Analysis of active ingredients of Conocarpus erectus on pseudomonas aeruginosa
DOI:
https://doi.org/10.56053/9.S.199Keywords:
Pseudomonas aeruginosa, Conocarpous, Cystic fibrosis (CF), GCmas assayAbstract
Pseudomonas aeruginosa, which causes recurrent infections, is one of the predominant pathogens in cystic fibrosis (CF) patients. A large variety of cell-associated and extracellular virulence factors that are involved in P. aeruginosa's pathogenesis and contribute to its pathogenesis provide this pathogen tremendous versatility. In this research, A GCmas assay are performed, quercetin is manufactured and measure the effect of different concentration of Conocarpous eractus extract and quercetin on
pseudomonas spp. Biofilm formation found that the first pseudomonas spp. isolate is more sensitive to antibiotics, so it is more sensitive to the plant extract, so it is the best result. Unlike the last isolate, where it is the strongest antibiotic resistant, so the effect of the extract is less severe, but it inhibited the biofilm.
References
-[1] F. S. Munaf, A. A. Haider, and A. I. Ahmed, AIP Conf. 442 (2024) 35
-[2] D. A. Alhasan, A. Q. Dawood, and A. D. Muter, Univ. Thi-Qar J., 14 (2019) 116
-[3] N. Marcar, S. Ismail, Hossain, and R. Ahmad, Canberra: ACIAR (1999)
-[4] N. M. Al-Musayeib, R. A. Mothana, S. Al-Massarani, A. Matheeussen, P. Cos, and L. Maes, Molecules, 17 (2012) 11379
-[5] E. S. S. Abdel-Hameed, S. A. Bazaid, M. M. Shohayeb, M. M. El-Sayed, and E. A. El-Wakil, Eur. J. Med. Plants, 2 (2012) 93
-[6] S. Touqeer, M. A. Saeed, F. Ansari, N. Zahra, Z. Masood, M. Fareed, and A. Javed, J. Appl. Pharm., 6 (2014) 153
-[7] F. S. Munaf, and A. I. Ahmed, J. Educ. Sci. Stud. 45 (2022) 59
-[8] N. Joudeh, and D. Linke, J. Nanobiotechnol., 20 (2022) 262
-[9] M. Bashir, M. Uzair, and B. A. Chaudhry, Pak. J. Pharm. Res., 1 (2015) 1
-[10] A. Gupta, R. B. Aniyery, and A. Pathak, Int. J. Pharm. Sci. Res., 8 (2017) 4201
-[11] R. Khalil, Q. Ali, and M. M. Hafeez, Biol. Clin. Sci. Res. J. 77 (2020) 39
-[12] G. Dong, J. Huang, and X. Du, J. Psychiatr. Res., 45 (2011) 1525
-[13] K. Amna, F. Muayad Shawkat, Plant Arch., 20 (2020) 3476
-[14] E. Kaya, L. Grassi, A. Benedetti, G. Maisetta, C. Pileggi, M. Di Luca, and S. Esin, Front. Cell. Infect. Microbiol., 10 (2020) 187
-[15] S. E. Cramton, C. Gerke, N. F. Schnell, W. W. Nichols, and F. Götz, Infect. Immun., 67 (1999) 5427
-[16] A. W. Shahwany, H. K. Tawfeeq, and S. E. Hamed, J. Biomed. Biotechnol., 4 (2016) 12
-[17] N. A. Al-Mothafar, and A. W. Al-Shahwany, Int. J. Health Sci., 6 (2022) 204
-[18] P. Ertl, B. Rohde, and P. Selzer, J. Med. Chem., 43 (2000) 3714
-[19] S. S. Moni, M. F. Alam, M. H. Sultan, H. A. Makeen, H. A. Alhazmi, S. Mohan, and T. Anwer, Braz. J. Biol., 83 (2021) 99
-[20] R. Boly, T. Gras, T. Lamkami, P. Guissou, D. Serteyn, R. Kiss, and J. Dubois, Int. J. Oncol., 38 (2011) 833
-[21] Y. Li, J. Yao, C. Han, J. Yang, M. T. Chaudhry, S. Wang, H. Liu, and Y. Yin, Nutrients, 8 (2016) 167
-[22] G. Wang, Y. Wang, L. Yao, W. Gu, S. Zhao, Z. Shen, Z. Lin, W. Liu, and T. Yan, Evid.-Based Complement. Alternat. Med. (2022)
-[23] C. G. Giske, J. Turnidge, R. Cantón, and G. Kahlmeter, J. Clin. Microbiol., 60 (2022) e00276
-[24] L. F. Mahdi, and A. H. Al-Azawi, Egypt. J. Hosp. Med., 89 (2022) 6961
-[25] N. M. Thuy, N. T. M. Tuyen, N. P. Cuong, L. T. N. Huyen, N. P. Phuong, L. T. T. Nguyen, J. H. Kim, N. T. Thu, and N. V. Tai, Food Res., 4 (2020) 358
-[26] Maria S. da Dunla, Exp. Theo. NANOTECHNOLOGY 8 (2024) 23
-[27] Ziyad Khalf Salih, Angham Ayad Kamall-Eldeen, Exp. Theo. NANOTECHNOLOGY 8 (2024) 27
-[28] Ghazal Tuhmaz, Exp. Theo. NANOTECHNOLOGY 8 (2024) 33
-[29] M. Tadres, Exp. Theo. NANOTECHNOLOGY 8 (2024) 11
